UK BRCA mutation testing in patients with ovarian cancer

Despite the increasing clinical importance of germline BRCA mutation status in managing women with ovarian cancer, few patients are currently being tested. The traditional means of selecting patients for BRCA mutation testing using restrictive criteria will miss many women with a mutation. To expand...

Descripción completa

Detalles Bibliográficos
Autor principal: George, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816269/
https://www.ncbi.nlm.nih.gov/pubmed/26669451
http://dx.doi.org/10.1038/bjc.2015.396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816269/
https://www.ncbi.nlm.nih.gov/pubmed/26669451
http://dx.doi.org/10.1038/bjc.2015.396

Ejemplares similares